Merck & Co Inc (MRK)
88.11
+0.24
(+0.27%)
USD |
NYSE |
Mar 26, 16:00
88.28
+0.17
(+0.19%)
Pre-Market: 05:25
Merck Shareholders Equity (Quarterly): 46.31B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 5.877B |
| Gilead Sciences Inc | 19.33B |
| Johnson & Johnson | 71.49B |
| Regeneron Pharmaceuticals Inc | 29.35B |
| Moderna Inc | 10.90B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 117.11B |
| Total Liabilities (Quarterly) | 70.73B |
| Debt to Equity Ratio | 0.8013 |
| Current Ratio | 1.365 |
| Net Debt Paydown Yield | -0.18% |